Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Coalition led by Iraqi PM al-Sudani wins parliamentary elections - 2SpaceX shatters its rocket launch record yet again — 165 orbital flights in 2025
- 3Looking for a great Thanksgiving side dish recipe? These are the crowd-pleasers the Yahoo team swears by.
- 4The Most Famous Virtual Entertainment Powerhouses of the Year
- 5Figure out how to Consolidate a Brain science Certificate with Social Work
- Audits of 6 Specialty Mixed drinks
- Allow Innovative Progressions To have a Massive Effect
- Audits of the Top Science fiction Movies This Year
- 4 Famous Attractions at Disneyland
- Investigate Business Mastercard Choices for Better Rewards and Rewards
- The Minimized Passage Horse: Reconsidering a Symbol for the Cutting edge Period
- Astronomers spot white dwarf star creating a colorful shockwave
- How grandchildren are stepping up to fill the caregiver gap
- Travel Through France's Most Iconic Wine Regions By Train On An Immersive Seven-Day Journey
